TFA Therapeutics (RAJAF) Non Operating Interest Expenses (2020)
TFA Therapeutics (RAJAF) posted Non Operating Interest Expenses of $20284.0 for Q4 2020.
Powered by 
Analysis
TFA Therapeutics (RAJAF) Non Operating Interest Expenses (2020) Analysis & Trends
TFA Therapeutics has reported Non Operating Interest Expenses for 1 years, with the latest figure at $20284.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 62.00 Mn |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | - |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | 53.00 Mn |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | 63.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | - |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 16.70 Mn |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 40.00 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 682.25 Mn | 576.35 Mn | 40.36 Mn | - |